Clinical Edge Journal Scan

Active disease in third trimester increases risk for emergency caesarean section in PsA


 

Key clinical point: Women with psoriatic arthritis (PsA) were at an increased risk for emergency caesarean section, with active disease in the third trimester further amplifying the risk, highlighting the importance of pregestational counseling and disease control along with systematic monitoring during pregnancy.

Major finding: Compared with control individuals, women with PsA had a higher risk for caesarean section (risk difference [RD] 15.0%; P < .001) and for emergency caesarean section (RD 10.6%; P < .001), with active disease in the third trimester further amplifying both risks (caesarean section: RD 17.7%; P = .028; emergency caesarean section: RD 15.9%; P = .015).

Study details: The data come from a population-based cohort study that included women with PsA (n = 121), women with axial spondyloarthritis (n = 312), and control individuals (n = 575,798) with singleton births.

Disclosures: This study was funded by The Norwegian Women’s Public Health Association. The authors did not declare any conflicts of interest.

Source: Skorpen CG et al. Caesarean section in women with axial spondyloarthritis and psoriatic arthritis: A population-based study. RMD Open . 2023;9(1):e002760 (Mar 2). Doi: 10.1136/rmdopen-2022-002760

Recommended Reading

New influx of Humira biosimilars may not drive immediate change
MDedge Rheumatology
Expert offers caveats to perioperative antirheumatic drug guideline
MDedge Rheumatology
What’s holding back physicians from prescribing biosimilars? Four specialties weigh in
MDedge Rheumatology
Treating nail psoriasis: Intralesional injections and biologics
MDedge Rheumatology
Isolated nail psoriasis may bring arthritis into play
MDedge Rheumatology
Commentary: Concerning PsA treatments and comorbidities, March 2023
MDedge Rheumatology
Biologics show signs of delaying arthritis in psoriasis patients
MDedge Rheumatology
Psoriatic arthritis treatment for women falls short, study suggests
MDedge Rheumatology
Gender-based differences in treatment outcomes and persistence with ustekinumab or TNFi in PsA
MDedge Rheumatology
Achievement of low disease activity improves long-term structural damage in PsA
MDedge Rheumatology